Plasmodium Immunotherapy for Breast and Liver Cancers

Clinical trial NCT03474822 · UNKNOWN

Trial details

NCT number: NCT03474822
Sponsor: CAS Lamvac Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Advanced Liver Cancer

Start date: 2018-08-10
Primary completion: 2023-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.